Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9533233 | 0.77 | RAB9A (0.46) | RAB9ASMN1; SMN2MEN1KMT2ACYP2D6 | |
| SCHEMBL5067712 | 0.74 | TSHR (0.43) | RAB9ASMN1; SMN2NPC1MEN1KMT2A | |
| SCHEMBL28302892 | 0.74 | MEN1 (0.48) | MEN1KMT2AHSD17B10 | |
| Phenylacetylene SCHEMBL27678817 | 0.67 | MEN1 (0.45) | MEN1KMT2AHSD17B10TSHR | |
| SCHEMBL859852 | 0.67 | HDAC8 (0.58) | MEN1KMT2AHSD17B10CYP2D6CA12 | |
| SCHEMBL13656487 | 0.66 | TSHR (0.43) | RAB9ASMN1; SMN2NPC1MEN1KMT2A | |
| SCHEMBL23950227 | 0.65 | HDAC8 (0.39) | CA12CA1CA2CA9 | |
| SCHEMBL13784878 | 0.65 | CA12 (0.40) | CA12CA1CA2CA9 | |
| SCHEMBL9536998 | 0.64 | CES2 (0.45) | RAB9ANPC1MEN1KMT2A | |
| SCHEMBL3838955 | 0.64 | SRD5A2 (0.48) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030482-B2 | 3-beta-tetrahydropyranyloxy-22-[4-(4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)butyroxy]-23-bisnorchol-5-ene, used in fluorescence spectroscopy for monitoring exchange, distribution and trafficking of cholesterol between living cells and lipid domains in membranes | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2011-10-04 | — | — | US | disclosed |
| US-20080177059-A1 | FREE CHOLESTEROL ANALOGS BEARING A BORON DIPYRROMETHENE DIFLUORO (BODIPY) FLUOROPHORE IN THE SIDE CHAIN AND METHOD OF PREPARATION AND USE THEREOF | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177059-A1 | FREE CHOLESTEROL ANALOGS BEARING A BORON DIPYRROMETHENE DIFLUORO (BODIPY) FLUOROPHORE IN THE SIDE CHAIN AND METHOD OF PREPARATION AND USE THEREOF | NPC1L1, CETP, NPC1 | RAB9A 747/4885SMN1; SMN2 4159/4885NPC1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.